---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-064624"
form_type: "8-K"
ticker: "RANI"
cik: "0001856725"
company_name: "Rani Therapeutics Holdings, Inc."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T14:04:22.909583+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Rani Therapeutics receives Nasdaq deficiency notice for MVLS below $50M

## Summary
- Nasdaq notified Rani on May 1, 2025 that its Market Value of Listed Securities was below $50M for 30 consecutive business days.
- Company has 180 calendar days, until October 28, 2025, to regain compliance by achieving MVLS >= $50M for 10 consecutive business days.
- If noncompliance persists, Nasdaq may delist; Rani could appeal or apply to transfer to Nasdaq Capital Market.
- Rani is considering actions to regain compliance but has not yet decided on a response.
- There is no assurance of regaining compliance or meeting other listing criteria.

## SEC filing metadata
- accession: 0000950170-25-064624
- form_type: 8-K
- ticker: RANI
- cik: 0001856725
- company_name: Rani Therapeutics Holdings, Inc.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1856725/000095017025064624/0000950170-25-064624-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1856725/000095017025064624/rani-20250501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-064624
- JSON: https://secwatch.observer/filing/0000950170-25-064624.json
- Plain text: https://secwatch.observer/filing/0000950170-25-064624.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.